SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis.

Vizier R, Garnier AR, Dias A, Moreau M, Claron M, Collin B, Denat F, Bellaye PS, Goncalves V

Open source

DOI
10.1021/acs.molpharmaceut.3c00232
Published
2023 Jul 3
Container
Molecular pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.3c00232,
  title = {SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis.},
  author = {Vizier R and Garnier AR and Dias A and Moreau M and Claron M and Collin B and Denat F and Bellaye PS and Goncalves V},
  year = {2023},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.3c00232},
  url = {https://doi.org/10.1021/acs.molpharmaceut.3c00232}
}

RIS

TY  - JOUR
TI  - SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis.
AU  - Vizier R
AU  - Garnier AR
AU  - Dias A
AU  - Moreau M
AU  - Claron M
AU  - Collin B
AU  - Denat F
AU  - Bellaye PS
AU  - Goncalves V
PY  - 2023
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.3c00232
UR  - https://doi.org/10.1021/acs.molpharmaceut.3c00232
ER  - 

APA

R, V., AR, G., A, D., M, M., M, C., B, C., F, D., PS, B., & V, G. (2023). SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00232

Source records